The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence

References

• JensenTSBaronRHaanpääMA new definition of neuropathic painPain2011152102204220521764514
   PubMed Web of Science ®Google Scholar
• SadoskyAMcDermottAMBrandenburgNAA review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditionsPain Pract200881455618211592
   PubMedGoogle Scholar
• WongCSHuiGKChungEKDiagnosis and management of neuropathic painPain Manag20144322123124953074
   PubMedGoogle Scholar
• SmithBHTorranceNEpidemiology of neuropathic pain and its impact on quality of lifeCurr Pain Headache Rep201216319119822395856
   PubMed Web of Science ®Google Scholar
• MickGBaronRHansGLocalized neuropathic pain: a proposed definitionEur J Pain Suppl20115S1275
   Google Scholar
• MickGBaronRCorrea-IllanesGIs an easy and reliable diagnosis of localized neuropathic pain (LNP) possible in general practice? Development of a screening tool based on IASP criteriaCurr Med Res Opin20143071357136624650347
   PubMed Web of Science ®Google Scholar
• MickGBaronRFinnerupNBWhat is localized neuropathic pain? A first proposal to characterize and define a widely used termPain Manage2012217177
   PubMedGoogle Scholar
• NalamachuSMorley-ForsterPDiagnosing and managing postherpetic neuralgiaDrugs Aging20122986386923038608
   PubMed Web of Science ®Google Scholar
• JohnsonRWRiceASClinical practice. Postherpetic neuralgiaN Engl J Med2014371161526153325317872
   PubMed Web of Science ®Google Scholar
• de Leon-CasasolaOA review of the literature on multiple factors involved in postoperative pain course and durationPostgrad Med20141264425225141242
   PubMed Web of Science ®Google Scholar
• DuracinskyMPaccalinMGavazziGARIZONA study: is the risk of post-herpetic neuralgia and its burden increased in the most elderly patients?BMC Infect Dis20141452925273329
   PubMed Web of Science ®Google Scholar
• SerpellMGaterACarrollSAbetz-WebbLMannanAJohnsonRBurden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the Zoster Quality of Life (ZQOL) studyHealth Qual Life Outcomes2014129224920439
   PubMed Web of Science ®Google Scholar
• SawynokJTopical analgesics for neuropathic pain: preclinical exploration, clinical validation, future developmentEur J Pain201418446548124108446
   PubMed Web of Science ®Google Scholar
• MickGCorrea-IllanesGTopical pain management with the 5% lidocaine medicated plaster – a reviewCurr Med Res Opin201228693795122551228
   PubMed Web of Science ®Google Scholar
• NavezMLMonellaCBöslI5% lidocaine medicated plaster for the treatment of postherpetic neuralgia: a review of the clinical safety and tolerabilityPain Ther20154111525896574
   PubMed Web of Science ®Google Scholar
• DubinskyRMKabbaniHEl-ChamiZQuality Standards Subcommittee of the American Academy of NeurologyPractice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of NeurologyNeurology200463695996515452284
   PubMed Web of Science ®Google Scholar
• FinnerupNBOttoMMcQuayHJJensenTSSindrupSHAlgorithm for neuropathic pain treatment: an evidence based proposalPain2005118328930516213659
   PubMed Web of Science ®Google Scholar
• AttalNCruccuGHaanpääMEFNS Task ForceEFNS guidelines on pharmacological treatment of neuropathic painEur J Neurol200613111153116917038030
   PubMed Web of Science ®Google Scholar
• DworkinRHO’ConnorABBackonjaMPharmacologic management of neuropathic pain: evidence-based recommendationsPain2007132323725117920770
   PubMed Web of Science ®Google Scholar
• AcevedoJCAmayaACasasola OdeLGuidelines for the diagnosis and management of neuropathic pain: consensus of a group of Latin American expertsJ Pain Palliat Care Pharmacother200923326128119670022
   PubMedGoogle Scholar
• O’ConnorABDworkinRHTreatment of neuropathic pain: an overview of recent guidelinesAm J Med200912210 supplS22S3219801049
   PubMed Web of Science ®Google Scholar
• AttalNCruccuGBaronREuropean Federation of Neurological SocietiesEFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revisionEur J Neurol20101791113112320402746
   PubMed Web of Science ®Google Scholar
• DworkinRHO’ConnorABAudetteJRecommendations for the pharmacological management of neuropathic pain: an overview and literature updateMayo Clin Proc2010853 supplS3S1420194146
   PubMed Web of Science ®Google Scholar
• FinnerupNBSindrupSHJensenTSThe evidence for pharmacological treatment of neuropathic painPain2010150357358120705215
   PubMed Web of Science ®Google Scholar
• ArgoffCEReview of current guidelines on the care of postherpetic neuralgiaPostgrad Med2011123513414221904096
   PubMed Web of Science ®Google Scholar
• FernándezRAhumadaMMuñozRGuía para definición y manejo del Dolor Neuropático localizado (DNL): Consenso Chileno [Guidelines for definition and management of localized neuropathic pain (LNP): Chilean consensus]Revista El Dolor2011551231
   Google Scholar
• WolffRFBalaMMWestwoodMKesselsAGKleijnenJ5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic reviewActa Neurol Scand2011123529530921039364
   PubMed Web of Science ®Google Scholar
• HardenRNKayeADKintanarTArgoffCEEvidence-based guidance for the management of postherpetic neuralgia in primary carePostgrad Med2013125419120223933906
   PubMed Web of Science ®Google Scholar
• FinnerupNBAttalNHaroutounianSPharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysisLancet Neurol201514216217325575710
   PubMed Web of Science ®Google Scholar
• PAINWeek [webpage on the Internet]BoeslIKoenigSMore than 20 million patients used 5% lidocaine medicated plaster: an update on its safety profilePAINWeek2014 [abstract no. 10]. Available from: http://conference.painweek.org/media/mediafile_attachments/04/724-painweek2014acceptedabstracts.pdfAccessed September 21, 2015
   Google Scholar
• SchmaderKEEpidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathyClin J Pain200218635035412441828
   PubMed Web of Science ®Google Scholar
• VevesABackonjaMMalikRAPainful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment optionsPain Med20089666067418828198
   PubMed Web of Science ®Google Scholar
• Van AckerKBouhassiraDDe BacquerDPrevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinicsDiabetes Metab200935320621319297223
   PubMed Web of Science ®Google Scholar
• Garnock-JonesKPKeatingGMLidocaine 5% medicated plaster: a review of its use in postherpetic neuralgiaDrugs200969152149216519791831
   PubMed Web of Science ®Google Scholar
• WolffRFBalaMMWestwoodMKesselsAGKleijnenJ5% lidocaine medicated plaster in painful diabetic peripheral neuropathy (DPN): a systematic reviewSwiss Med Wkly201014021–2229730620458651
   PubMed Web of Science ®Google Scholar
• RowbothamMCDaviesPSVerkempinckCGalerBSLidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgiaPain199665139448826488
   PubMed Web of Science ®Google Scholar
• GalerBSRowbothamMCPeranderJFriedmanETopical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment studyPain199980353353810342414
   PubMed Web of Science ®Google Scholar
• BinderABruxelleJRogersPHansGBöslIBaronRTopical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trialClin Drug Investig2009296393408
   PubMed Web of Science ®Google Scholar
• WasnerGKleinertABinderASchattschneiderJBaronRPostherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skinJ Neurol2005252667768615778907
   PubMed Web of Science ®Google Scholar
• MeierTWasnerGFaustMEfficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled studyPain20031061–215115814581122
   PubMed Web of Science ®Google Scholar
• CasaleRDi MatteoMMinellaCEFanelliGAllegriMReduction of painful area as new possible therapeutic target in post-herpetic neuropathic pain treated with 5% lidocaine medicated plaster: a case seriesJ Pain Res2014735335725018649
   PubMed Web of Science ®Google Scholar
• Correa-IllanesGRoaRPiñerosJLCalderónWUse of 5% lidocaine medicated plaster to treat localized neuropathic pain secondary to traumatic injury of peripheral nervesLocal Reg Anesth20125475323152700
   PubMedGoogle Scholar
• WoolfCJCentral sensitization: uncovering the relation between pain and plasticityAnesthesiology2007106486486717413924
   PubMed Web of Science ®Google Scholar
• WhiteWTPatelNDrassMNalamachuSLidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic painPain Med20034432133014750908
   PubMed Web of Science ®Google Scholar
• BarbanoRLHerrmannDNHart-GouleauSPennella-VaughanJLodewickPADworkinRHEffectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathyArch Neurol200461691491815210530
   PubMedGoogle Scholar
• ArgoffCEGalerBSJensenMPOlekaNGammaitoniAREffectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain ScaleCurr Med Res Opin200420suppl 2S21S2815563743
   PubMed Web of Science ®Google Scholar
• BaronRMayoralVLeijonGBinderASteigerwaldISerpellM5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT studyCurr Med Res Opin20092571663167619485723
   PubMed Web of Science ®Google Scholar
• BaronRMayoralVLeijonGBinderASteigerwaldISerpellMEfficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathyCurr Med Res Opin20092571677168719480610
   PubMed Web of Science ®Google Scholar
• BaronRMayoralVLeijonGBinderASteigerwaldISerpellMEfficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trialClin Drug Investig2009294231241
   PubMed Web of Science ®Google Scholar
• RehmSBinderABaronRPost-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness studyCurr Med Res Opin20102671607161920429825
   PubMed Web of Science ®Google Scholar
• de Leon-CasasolaOAMultimodal, multiclass, multidisciplinary therapy: the key to better analgesia in the 21st century?Clin J Pain201026suppl 10S1S220026959
   PubMed Web of Science ®Google Scholar
• DalpiazASDoddsTAMyofascial pain response to topical lidocaine patch therapy: case reportJ Pain Palliat Care Pharmacother20021619910414650453
   PubMedGoogle Scholar
• AffaitatiGFabrizioASaviniAA randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholdsClin Ther200931470572019446144
   PubMed Web of Science ®Google Scholar
• LinYCKuanTSHsiehPCYenWJChangWCChenSMTherapeutic effects of lidocaine patch on myofascial pain syndrome of the upper trapezius: a randomized, double-blind, placebo-controlled studyAm J Phys Med Rehabil2012911087188222854911
   PubMed Web of Science ®Google Scholar
• Orellana SilvaMYañezVHidalgoGValenzuelaFSaavedraR5% lidocaine medicated plaster use in children with neuropathic pain from burn sequelaePain Med201314342242923279572
   PubMed Web of Science ®Google Scholar
• MattozziITrattamento conservativo della radicolopatia cervicale con lidocaina cerotto 5% [Conservative treatment of cervical radiculopathy with 5% lidocaine medicated plaster]Minerva Med2015105117 Italian25582970
   PubMed Web of Science ®Google Scholar
• BischoffJMPetersenMUçeylerNSommerCKehletHWernerMULidocaine patch (5%) in treatment of persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled, crossover trialAnesthesiology201311961444145223887198
   PubMed Web of Science ®Google Scholar
• ChevilleALSloanJANorthfeltDWUse of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB)Support Care Cancer200917445146019142669
   PubMed Web of Science ®Google Scholar
• KernKUNalamachuSBrasseurLZakrzewskaJMCan treatment success with 5% lidocaine medicated plaster be predicted in cancer pain with neuropathic components or trigeminal neuropathic pain?J Pain Res2013626128023630431
   PubMed Web of Science ®Google Scholar
• CasaleRRomanenkoYAllegriM5% lidocaine medicated plaster double effect in a case of orofacial localized neuropathic painJ Pain Res2014763964325473307
   PubMed Web of Science ®Google Scholar
• CrutoMEBaricocchiEBattistellaMTrattamento del “persistent postmastectomy pain” con Lidocaina cerotto 5% [Treatment of persistent postmastectomy pain with 5% lidocaine medicated plaster]Minerva Chir2015702147153 Italian25815700
   PubMed Web of Science ®Google Scholar
• LikarRDemscharSKagerINeuwerschSPipamWSittlRTreatment of localized neuropathic pain of different etiologies with the 5% lidocaine medicated plaster – a case seriesInt J Gen Med2015891425565882
   PubMedGoogle Scholar
• KatzNPGammaitoniARDavisMWDworkinRHLidoderm Patch Study GroupLidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trialPain Med20023432433215099237
   PubMed Web of Science ®Google Scholar
• ClèreFDelorme-MorinCGeorgeB5% lidocaine medicated plaster in elderly patients with postherpetic neuralgia: results of a compassionate use programme in FranceDrugs Aging201128969370221913735
   PubMed Web of Science ®Google Scholar
• ÜberallMAMüller-SchwefeGHPatient perceptions associated with the 5% lidocaine medicated plaster in daily practiceCurr Med Res Opin201228690190922506624
   PubMed Web of Science ®Google Scholar
• FogliardiABrunoriCEsperienza con lidocaina cerotto 5% nel trattamento del dolore neuropatico localizzato [Experience with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain]Minerva Med20131046631637 Italian24316916
   PubMed Web of Science ®Google Scholar
• KhotSMorganCLKadambandeSPooleCDUse of 5% lidocaine medicated plasters for the treatment of pain in routine hospital practice: patient reported pain, functioning and satisfactionCurr Med Res Opin20143081573157824773481
   PubMed Web of Science ®Google Scholar
• ProvincialiLLattanziSChiarloneRTopical pharmacologic approach with 5% lidocaine medicated plaster in the treatment of localized neuropathic painMinerva Med2014105651552725392960
   PubMed Web of Science ®Google Scholar
• HansGSabatowskiRBinderABoeslIRogersPBaronREfficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term studyCurr Med Res Opin20092551295130519366301
   PubMed Web of Science ®Google Scholar
• SabatowskiRHansGTackenIKapanadzeSBuchheisterBBaronRSafety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgiaCurr Med Res Opin20122881337134622769236
   PubMed Web of Science ®Google Scholar
• DelormeCNavezMLLegoutVDeleensRMoyseDTreatment of neuropathic pain with 5% lidocaine-medicated plaster: five years of clinical experiencePain Res Manag201116425926322059196
   PubMed Web of Science ®Google Scholar
• GalerBSGammaitoniARMore than 7 years of consistent neuropathic pain relief in geriatric patientsArch Intern Med2003163562812622611
   PubMedGoogle Scholar
• US Food and Drug Administration [webpage on the Internet]Guidance for industry. Analgesic indications: developing drug and biological products (draft guidance) Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm384691.pdfAccessed September 21, 2015
   Google Scholar
• McQuayHJDerrySMooreRAPoulainPLegoutVEnriched enrolment with randomised withdrawal (EERW): time for a new look at clinical trial design in chronic painPain2008135321722018258369
   PubMed Web of Science ®Google Scholar
• MooreRAWiffenPJEcclestonCSystematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reportingPain201515681382139525985142
   PubMed Web of Science ®Google Scholar
• FurlanADChaparroLEIrvinEMailis-GagnonAA comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer painPain Res Manag201116533735122059206
   PubMed Web of Science ®Google Scholar
• GilronIBaileyJMTuDHoldenRRWeaverDFHouldenRLMorphine, gabapentin, or their combination for neuropathic painN Engl J Med2005352131324133415800228
   PubMed Web of Science ®Google Scholar
• GilronIBaileyJMTuDHoldenRRJacksonACHouldenRLNortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trialLancet200937496971252126119796802
   PubMed Web of Science ®Google Scholar
• de Leon-CasasolaONew developments in the treatment algorithm for peripheral neuropathic painPain Med201112suppl 3S100S10821752181
   PubMed Web of Science ®Google Scholar
• KatzJFinnerupNBDworkinRHClinical trial outcome in neuropathic pain: relationship to study characteristicsNeurology200870426327217914067
   PubMed Web of Science ®Google Scholar
• VaseLPetersenGLLundKPlacebo effects in idiopathic and neuropathic pain conditionsHandb Exp Pharmacol201422512113625304529
   PubMedGoogle Scholar
• VaseLAmanzioMPriceDDNocebo vs. placebo: the challenges of trial design in analgesia researchClin Pharmacol Ther201597214315025670519
   PubMed Web of Science ®Google Scholar
• DerrySWiffenPJMooreRAQuinlanJTopical lidocaine for neuropathic pain in adultsCochrane Database Syst Rev20147CD01095825058164
   PubMed Web of Science ®Google Scholar
• CasaleRMattiaCBuilding a diagnostic algorithm on localized neuropathic pain (LNP) and targeted topical treatment: focus on 5% lidocaine-medicated plasterTher Clin Risk Manag20141025926824790451
   PubMed Web of Science ®Google Scholar
• BruckenthalPBarkinRLOptions for treating postherpetic neuralgia in the medically complicated patientTher Clin Risk Manag2013932934023990726
   PubMed Web of Science ®Google Scholar